Chickenpox / Shingles in Pregnant Women
RCOG Chickenpox in Pregnancy (Green-top Guideline No.13). Last reviewed 2024.
Background Information
Chickenpox and Shingles
Both chickenpox and shingles are caused by varicella-zoster virus (VZV) (human herpesvirus 3):
- Chickenpox = primary VZV infection
- Shingles (herpes zoster) = reactivation of VZV from sensory nerve root ganglia, following primary infection
Complications
Maternal consequences:
- Pneumonia
- Hepatitis
- Encephalitis
Fetal / baby consequences:
- Spontaneous miscarriage (only in 2nd and 3rd trimester)
- Fetal varicella syndrome
- Risk is highest following maternal infection during the first 20 weeks (low risk >20 weeks)
- Characterised by several congenital anomalies
- Neonatal varicella
- May occurs if maternal infection occurs in the month before delivery
- Maternal infection from 5 days before to 2 days after delivery has the highest risk of severe, disseminated infection
- Shingles in infancy
- Due to reactivation of latent VZV acquired either in utero (asymptomatic or minimally symptomatic infection) or postnatally.
- It presents as a dermatomal vesicular eruption, usually within the first year of life.
Guidelines
Chickenpox / Shingles Exposure in Pregnancy
Step 1: determine VZV immunity status
- If the patient is uncertain or has no previous history of chickenpox → serology testing for VZV antibodies
- If patient had previous chickenpox or +ve serology → immune to VZV → no further action (note this is not explicitly stated in the guidelines but assumed)
Step 2: treat pregnant women who are NOT immune to VZV and have significant exposure with PEP (post-exposure prophylaxis)
Choice of PEP:
- 1st line: oral aciclovir / valaciclovir to be given 7-14 days post-exposure
- 2nd line: IM VZIG to be given within 10 days post-exposure
Pregnant Women Who Develop Chickenpox
- Symptomatic treatment and hygiene – to prevent secondary bacterial infection
Anti-viral therapy
- Severe/complicated chickenpox → IV aciclovir
- Uncomplicated chickenpox presenting <24 hours after rash onset → oral aciclovir
- RCOG states offer if >20 weeks gestation, and consider if <20 weeks gestation
Women should avoid contact with potentially susceptible individuals, e.g. other pregnant women and neonates, until the lesions have crusted over. This is usually about 5 days after the onset of the rash.
VZIG has no therapeutic benefit once chickenpox has developed; therefore, it should not be used in pregnant women who DEVELOP chickenpox.
VZIG is only used in the context of chickenpox/shingles post-EXPOSURE prophylaxis.